1. | It appears that your tabular presentations of GAAP and Adjusted Consolidated Statement of Income attach undue prominence to non-GAAP information. Accordingly, please revise your presentation to comply with Item 10(e)(1)(i)(A) of Regulation S-K and Instruction 2 to Item 2.02 of Form 8-K to eliminate full non-GAAP income statements. For additional guidance, please refer to Question 102.10 of the Compliance and Disclosure Interpretation on Non-GAAP Financial Measures. |
2. | It also appears that your references to Adjusted Earnings per Share, Consolidated Adjusted Net Income, and Consolidated Adjusted EBITDAR in the introduction of, and throughout your earnings release, attach undue prominence to these non-GAAP measures without presentation of the most directly comparable GAAP measures. Accordingly, please revise your presentation to comply with Item 10(e)(1)(i) of Regulation S-K. |
• | GAAP EPS for the quarter was $X.XX, an increase of XX.X%, and adjusted EPS were $X.XX, an increase of XX.X% over the prior year quarter(1); |
• | Consolidated net income increase XX.X% over the prior year quarter to $XX.X million and consolidated adjusted net income climbed XX.X% over the prior year quarter to $XX.X million(1); |
• | Consolidated EBITDAR for the quarter was $XX.X million, an increase of XX.X%, and consolidated adjusted EBITDAR was $XXX.X million for the quarter, an increase of XX.X%(1); |
• | Same-store revenue for all segments grew by X.X% over the prior year quarter, and same-store TSA revenue grew by X.X% over the prior year quarter; |
• | Same store skilled revenue mix increased by XXX basis points over the prior year quarter to XX.X%; |
• | Cornerstone Healthcare, Inc., our home health and hospice subsidiary, grew its revenue by $XX.X million to $XX.X million for the quarter, an increase of XX.X% over the prior year quarter; and |
• | Consolidated revenues for the quarter were up $XX.X million or XX.X% over the prior year quarter to $XXX.X million. |
• | the company is responsible for the adequacy and accuracy of the disclosure in the filing; |
• | staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and |
• | the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. |
Sincerely, | ||
/s/ Suzanne D. Snapper | ||
Suzanne D. Snapper | ||
Chief Financial Officer | ||
cc: | Christopher R. Christensen, Chief Executive Officer Chad A. Keetch, Executive Vice President and Secretary Beverly B. Wittekind, Vice President & General Counsel Craig Mordock, Sheppard Mullin Richter & Hampton LLP, SEC Counsel |
Three Months Ended March 31, | ||||||||
2016 | 2015 | |||||||
Revenue | $ | — | $ | — | ||||
Expense: | ||||||||
Cost of services (exclusive of rent, general and administrative and depreciation and amortization expense shown separately below) | — | — | ||||||
Rent—cost of services | — | — | ||||||
General and administrative expense | — | — | ||||||
Depreciation and amortization | — | — | ||||||
Total expenses | — | — | ||||||
Income from operations | — | — | ||||||
Other income (expense): | ||||||||
Interest expense | — | — | ||||||
Interest income | — | — | ||||||
Other expense, net | — | — | ||||||
Income before provision for income taxes | — | — | ||||||
Provision for income taxes | — | — | ||||||
Net income | — | — | ||||||
Less: net income (loss) attributable to noncontrolling interests | — | — | ||||||
Net income attributable to The Ensign Group, Inc. | $ | — | $ | — | ||||
Net income per share | ||||||||
Basic: | $ | — | $ | — | ||||
Diluted: | $ | — | $ | — | ||||
Weighted average common shares outstanding: | ||||||||
Basic | — | — | ||||||
Diluted | — | — | ||||||
Three Months Ended March 31, | ||||||||
2016 | 2015 | |||||||
Net income attributable to The Ensign Group, Inc. | $ | — | $ | — | ||||
Growth Rate % | — | % | ||||||
Non-GAAP adjustments | ||||||||
Urgent care center losses(a) | ||||||||
Costs incurred for facilities currently being constructed and other start-up operations(b) | — | — | ||||||
Acquisition related costs(c) | — | — | ||||||
Patient base amortization(d) | — | — | ||||||
Stock-based compensation expense(e) | — | — | ||||||
Professional service fees(f) | — | — | ||||||
Costs incurred related to new systems implementation(g) | — | — | ||||||
Noncontrolling interests(h) | — | — | ||||||
Provision for income taxes | ||||||||
Tax effect on Non-GAAP adjustments(i) | — | — | ||||||
Non-GAAP Net Income | $ | — | $ | — | ||||
— | % | |||||||
Diluted Earnings Per Share As Reported | ||||||||
Net Income | $ | — | $ | — | ||||
Average number of shares outstanding | — | — | ||||||
Adjusted Diluted Earnings Per Share | ||||||||
Net Income | $ | — | $ | — | ||||
Average number of shares outstanding | — | — | ||||||